絞り込み

16645

広告

Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.

著者 Russo V , Carbone A , Attena E , Rago A , Mazzone C , Proietti R , Parisi V , Scotti A , Nigro G , Golino P , D'Onofrio A
Clin Ther.2019 Nov 14 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (44view , 0users)

Full Text Sources

Miscellaneous

The use of direct oral anticoagulants (DOACs) in patients with atrial fibrillation (AF) and bioprosthetic heart valve is still controversial. The aim of this study was to compare the tolerability and effectiveness of treatment with DOACs versus vitamin K antagonists (VKAs) in patients with AF and a bioprosthetic heart valve in clinical practice.
PMID: 31735436 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード